Arterial age as a substitute for chronological age in the AGLA risk function could improve coronary risk prediction

Michel Romanens1, Franz Ackermann2, Isabella Sudano3

  • 1Vascular Risk Foundation, Olten, Switzerland.

Swiss Medical Weekly
|July 29, 2014
PubMed

Insights

Arterial age, calculated from carotid plaque, better predicts myocardial infarction risk than chronological age in coronary risk charts. This ultrasound-based method offers improved cardiovascular risk assessment for patients.

Area of Science:

  • Cardiovascular Medicine
  • Medical Imaging
  • Risk Stratification

Background:

  • Coronary risk charts like the Swiss Arbeitsgruppe Lipide und Atherosklerose (AGLA) have limited sensitivity for predicting future myocardial infarction.
  • Arterial age (aa) is explored as a potential surrogate for chronological age (ca) to enhance risk prediction.

Purpose of the Study:

  • To evaluate the performance of arterial age (aa) as a predictor of myocardial infarction compared to chronological age (ca).
  • To assess if arterial age can improve the accuracy of the AGLA coronary risk function.

Main Methods:

  • Carotid plaque burden was quantified using total plaque area (TPA) via ultrasound in a derivation cohort (n=1500).
  • An exponential function derived sex-specific formulas for arterial age based on TPA.
  • The predictive ability of AGLA using chronological age (AGLAca) and arterial age (AGLAaa) was validated in an external cohort (n=684) for detecting myocardial infarctions.

Main Results:

  • Arterial age formulas were established: men y = 5.4175e0.0426x, women y = 4.1942e0.0392x.
  • Receiver operating characteristic (ROC) analysis showed a significantly higher area under the curve for AGLAaa (0.78) compared to AGLAca (0.65).
  • Cox regression analysis confirmed AGLAaa's significant association with event-free survival (p=0.0003), unlike AGLAca.

Conclusions:

  • Arterial age derived from carotid plaque total plaque area (TPA) can effectively replace chronological age in the AGLA coronary risk function.
  • The use of arterial age demonstrates superior predictive performance for myocardial infarction.
  • Further research is warranted to validate these findings externally and assess the cost-effectiveness of ultrasound imaging for arterial age determination.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
365
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
350
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
925
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
377
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
384